Merck KGaA, Darmstadt, Germany Announces Partnerships to Advance Materials for Flexible, Foldable and Rollable OLED Displays
- Partnerships with Optitune and Solip Tech will allow the company to accelerate the commercialization of liviFlexTM, a new range of display materials that addresses challenges in the manufacture of flexible, foldable and rollable OLED displays.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced partnership agreements with Optitune Oy, Oulu, Finland and Solip Tech Co., Ltd., Daejeon, South Korea, to bring the first products under the new umbrella brand liviFlexTM to the display market. liviFlexTM offers a novel range of display materials that addresses challenges in the manufacture of flexible, foldable and rollable OLED displays, which are known as free-form displays. With its Performance Materials business sector, Merck KGaA, Darmstadt, Germany is a leading player in the electronic materials market and materials for OLED displays are one of the defined investment focus areas for future growth.
“Free-form devices are one of the fastest-growing trends in data-driven electronics,” says Michael Heckmeier, Head of the Display Solutions business unit within the Performance Materials business sector of Merck KGaA, Darmstadt, Germany. “Our partnership with Optitune and Solip Tech allowed us to quickly respond to the market requirement to develop robust and reliable solutions for our display customers. We are excited to bring our first liviFlex products to the market and look forward to further tapping into this exciting field of free-form displays.”
The first liviFlex™ series is called liviFlexTM-H, which offers versatile and customizable hard coat solutions. These polymerizable solutions cover all key technology parameters for free-form devices: hardness, scratch resistance, flexibility, and optical characteristics, such as transparency and color. With these partnerships, Merck KGaA, Darmstadt, Germany is combining new R&D capabilities and material systems with decades of experience in delivering highly reliable and superior quality solutions to the display industry. Financial terms were not disclosed.
Free-form displays bring new challenges to the display industry
Contrary to the flat, rectangular shape of standard displays, free-form OLED displays offer bespoke shapes and novel design features with surfaces that can be bent, folded, stretched, or rolled. In order to enable these properties, the display materials in these devices must be thin yet robust to prevent display stress caused by continuous folding and rolling. Compared with standard displays, free-form OLED displays require a reduction of about 60% of the display module’s thickness.
Revenues of free-form displays are expected to reach US$ 8.9 billion by 2025, which is 13 times the revenue generated by this segment today.1
1. OMDIA Amoled & Flexible Display Technology Tracker Q1 2020
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany, generated sales of € 16.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA, Darmstadt, Germany, has acquired Massachusetts-based Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the “Breez™”.